This page describes pharmacological agents that may have legal restrictions, side effects, and drug interactions in your jurisdiction. Information is for educational research only — consult a clinician before considering any compound.

Compact view
Research pass: stub-manual Compound OTHER LOW

Gerovital

Extended Research
Extended Research

Our depth — beyond the mirror

Deeper analysis, verdict reasoning, and per-archetype recommendations from our research team.

Editor's verdict OTHER LOW

"MANUAL-STUB. Ana Aslan's procaine HCl-based formulation developed in 1950s Romania, marketed as a longevity + anti-depressant agent. Claims of MAO inhibition and cognitive benefit; modern controlled studies have not replicated the original claims. Procaine itself has a short half-life and limited oral bioavailability. Treat as historical artifact + clinical curiosity unless re-investigation surfaces. Verdict likely SKIP after research-pass."

Research pass: stub-manual

How was your experience with this compound?

Anonymous · one vote per session · results below at 5+ votes.

Loading…

See something off?

Most of this wiki is AI-generated. Suggest a correction, dosing update, or new evidence — we review every submission.

Discussion — click to load
Loading…